Healthcare staffing company AMN Healthcare Services (NYSE:AMN) will be announcing earnings results this Thursday afternoon. Here’s what investors should know.
AMN Healthcare Services beat analysts’ revenue expectations by 2.9% last quarter, reporting revenues of $689.5 million, down 16% year on year. It was a very strong quarter for the company, with an impressive beat of analysts’ EPS estimates and a narrow beat of analysts’ sales volume estimates.
Is AMN Healthcare Services a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting AMN Healthcare Services’s revenue to decline 11.9% year on year to $652.8 million, improving from the 25.3% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.19 per share.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. AMN Healthcare Services has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 1.8% on average.
Looking at AMN Healthcare Services’s peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Pediatrix Medical Group’s revenues decreased 7% year on year, beating analysts’ expectations by 1%, and The Ensign Group reported revenues up 18.5%, topping estimates by 0.7%. The Ensign Group traded up 8.7% following the results.
Read our full analysis of Pediatrix Medical Group’s results here and The Ensign Group’s results here.
Debates around the economy’s health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.1% on average over the last month. AMN Healthcare Services is down 17.6% during the same time and is heading into earnings with an average analyst price target of $26.07 (compared to the current share price of $17.49).
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.